NGM Biopharmaceuticals, Inc. Profile Avatar - Palmy Investing

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an enginee…

Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared NGM Biopharmaceuticals, Inc. (NGM) to it's peer group.

Peer Group
Loading...
End of NGM's Analysis
CIK: 1426332 CUSIP: 62921N105 ISIN: US62921N1054 LEI: - UEI: -
Secondary Listings
NGM has no secondary listings inside our databases.